The Indian Council of Medical Research (ICMR) has recently introduced the country's first ethical guidelines for the application of artificial intelligence (AI) in biomedical research and healthcare. The guidelines are aimed at providing an ethical framework for the development of AI-based tools to benefit all stakeholders.
AI in healthcare is largely dependent on data obtained from human participants, and as such, raises concerns related to potential biases, data handling, interpretation, autonomy, risk minimization, professional competence, data sharing, and confidentiality. To address these concerns, the ICMR has developed these guidelines to ensure that ethical principles are considered while developing and deploying AI-based solutions in healthcare.
 |
| AI in Biomedical Research and Healthcare |
The adoption of AI technology in healthcare is rapidly growing in India. However, AI as a data-driven technology has potential ethical challenges, including algorithmic transparency and explainability, clarity on liability, accountability and oversight, bias and discrimination, among others. The ICMR Director General, Dr. Rajiv Behl, emphasizes the need to develop guiding ethical principles concerning artificial intelligence and machine learning-based tools for healthcare and biomedical research. The guidelines are intended for all stakeholders involved in research on AI in healthcare, including creators, developers, technicians, researchers, clinicians, ethics committees, institutions, sponsors, and funding organizations. They include separate sections addressing ethical principles for AI in health, guiding principles for stakeholders, the ethics review process, governance of artificial intelligence for healthcare and research, and the informed consent process involving human participants and their data.
These guidelines were formulated after extensive discussions with subject experts, researchers, and ethicists. The document notes that AI in healthcare has the potential to solve significant challenges such as diagnosis and screening, therapeutics, preventive treatments, clinical decision-making, public health surveillance, complex data analysis, and predicting disease outcomes. The purpose of these guidelines is not to limit innovation or recommend any disease-specific diagnostic or therapeutic approach. Instead, they aim to guide the effective and safe development, deployment, and adoption of AI-based technologies in biomedical research and healthcare delivery. These guidelines will be used by experts and ethics committees reviewing research proposals involving the use of AI-based tools and technologies.
The guidelines provide an ethical framework for the application of AI in biomedical research and healthcare, and address important issues such as data privacy, transparency, and accountability. The guidelines also emphasize the need for stakeholder involvement and public consultation in the development of AI-based technologies for healthcare. One of the key principles outlined in the guidelines is the importance of informed consent in research involving human participants and their data. The guidelines state that the process of obtaining informed consent should be transparent and accessible, and should ensure that participants fully understand the implications of their participation in the research. The guidelines also recommend the use of appropriate safeguards to protect the privacy and confidentiality of research participants.
Another important principle is the need for algorithmic transparency and explainability. The guidelines recommend that AI algorithms used in healthcare should be transparent, explainable, and auditable to ensure that they are fair, unbiased, and accountable. The guidelines also recommend that the development and use of AI algorithms should be subject to independent review and oversight to ensure that they meet ethical standards and do not harm patients.
The guidelines also address issues related to bias and discrimination in AI-based technologies for healthcare. The guidelines recommend that AI algorithms should be designed to minimize bias and discrimination, and that they should be tested for fairness and accuracy using appropriate datasets. The guidelines also recommend that the development and use of AI-based technologies should be subject to ongoing monitoring and evaluation to ensure that they do not perpetuate or exacerbate existing social inequalities. The guidelines further recommend that the use of AI in healthcare should be governed by appropriate regulatory frameworks and standards. The guidelines emphasize the need for clear guidance on liability and accountability for AI-based technologies, and recommend that stakeholders involved in the development and use of AI in healthcare should be subject to appropriate legal and ethical standards.
The Ethical Guidelines for the Application of Artificial Intelligence in Biomedical Research and Healthcare provide an important framework for the development, deployment, and adoption of AI-based technologies in healthcare. The guidelines emphasize the need for ethical principles, stakeholder involvement, and public consultation in the development of AI-based technologies for healthcare, and provide important guidance on issues such as data privacy, transparency, and accountability. By promoting the ethical use of AI in healthcare, these guidelines have the potential to enhance the quality of healthcare and improve patient outcomes.